In vivoimaging reveals selective PPAR activity in the skin of peroxisome proliferator-activated receptor responsive element-luciferase reporter mice

Reduced size of sebaceous gland and altered sebum lipid composition in mice lacking fatty acid binding protein 5 gene

(2012) Tomoko Sugawara et al.   EXPERIMENTAL DERMATOLOGY

Mice lacking epidermal PPARγ exhibit a marked augmentation in photocarcinogenesis associated with increased UVB-induced apoptosis, inflammation and barrier dysfunction

(2012) Ravi P. Sahu et al.   INTERNATIONAL JOURNAL OF CANCER

Targeting Peroxisome Proliferator-Activated Receptors (PPARs): Development of Modulators

(2012) Céline Pirat et al.   JOURNAL OF MEDICINAL CHEMISTRY

Novel insights on imaging sex hormone-dependent tumourigenesis in vivo

(2011) Balaji Ramachandran et al.   ENDOCRINE-RELATED CANCER

PPARgamma activators stimulate aquaporin 3 expression in keratinocytes/epidermis

(2011) Yan J. Jiang et al.   EXPERIMENTAL DERMATOLOGY

5,7-Dimethoxyflavone, an activator of PPARα/γ, inhibits UVB-induced MMP expression in human skin fibroblast cells

(2011) Jae Kyung Kim et al.   EXPERIMENTAL DERMATOLOGY

Peroxisome proliferator–activated receptor γ–mediated suppression of dendritic cell function prevents the onset of atopic dermatitis in NC/Tnd mice

(2011) Kyungsook Jung et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

HDACs class II-selective inhibition alters nuclear receptor-dependent differentiation

(2010) Angela Nebbioso et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Targeting PPAR receptors in the airway for the treatment of inflammatory lung disease

(2009) Maria G Belvisi et al.   BRITISH JOURNAL OF PHARMACOLOGY

PPARδ is a fatty acid sensor that enhances mitochondrial oxidation in insulin-secreting cells and protects against fatty acid-induced dysfunction

(2009) Kim Ravnskjaer et al.   JOURNAL OF LIPID RESEARCH

In Vivo Imaging Reveals Selective Peroxisome Proliferator Activated Receptor Modulator Activity of the Synthetic Ligand 3-(1-(4-Chlorobenzyl)-3-t-butylthio-5-isopropylindol-2-yl)-2,2-dimethylpropanoic acid (MK-886)

(2008) A. Biserni et al.   MOLECULAR PHARMACOLOGY